Anti-angiogenesis therapy using multikinase inhibitors not only prunes blood vessels essential for cancer progression and metastasis but also has immune modulatory effects by increasing M1 polarization of macrophages and stimulating CD8+ T-cell function (111–113). Here, CD8A is linked to cancer.